Auriculin



Compound IDCDAMM00186
Common nameAuriculin
IUPAC name5-hydroxy-7-(2-hydroxy-4-methoxyphenyl)-2,2-dimethyl-10-(3-methylbut-2-enyl)pyrano[3,2-g]chromen-6-one
Molecular formulaC26H26O6

Experimental data

Retention time48.94
Adduct[M+Na]+
Actual mz457.161
Theoretical mz457.162
Error1.96
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score4.8897

Identifiers and class information

Inchi keyVQGWUEFARIAFPF-UHFFFAOYSA-N
SmilesCC(=CCC1=C2C(=C(C3=C1OC=C(C3=O)C4=C(C=C(C=C4)OC)O)O)C=CC(O2)(C)C)C
SuperclassPhenylpropanoids and polyketides
ClassIsoflavonoids

Pharmacokinetic properties

Number of descriptor values(#stars)1
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)6
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-1
Molecular weight (mol_MW)434.488
Computed dipole moment(dipole)3.783
Total solvent accessible surface area (SASA)716.516
Hydrophobic component of SASA (FOSA)372.845
Hydrophilic component of SASA (FISA)109.885
Pie component of the SASA (PISA)233.786
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1325.27
Number of hydrogen bond donors (donorHB)1
Number of hydrogen bond acceptors (accptHB)4.5
Free energy of solvation of dipole (dip^2/V)0.0107998
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0062804
Globularity descriptor (glob)0.814347
Predicted polarizability in cubic angstroms (QPpolrz)45.264
Predicted hexadecane/gas partition coefficient (QPlogPC16)13.187
Predicted octanol/gas partition coefficient (QPlogPoct)18.893
Predicted water/gas partition coefficient (QPlogPw)8.355
Predicted octanol/water partition coefficient (QPlogPo/w)5.242
Predicted aqueous solubility (QPlogS)-6.688
Conformation-independent predicted aqueous solubility (CIQPlogS)-7.395
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.651
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)899.212
Predicted brain/blood partition coefficient (QPlogBB)-0.903
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)441.042
Predicted skin permeability, log Kp (QPlogKp)-2.145
PM3 calculated ionization potential (IP(ev))8.679
PM3 calculated electron affinity (EA(eV))0.514
Number of likely metabolic reactions (#metab)6
Prediction of binding to human serum albumin (QPlogKhsa)1.094
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)100
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)86.103
Number of nitrogen and oxygen atoms (#NandO)6
Number of violations of Lipinski’s rule of five (RuleOfFive)1
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P19838NFKB1Nuclear factor NF-kappa-B p105 subunitT83145SEA
P11926ODC1Ornithine decarboxylaseT60366SEA
P18031PTPN1Protein-tyrosine phosphatase 1BT16347SEA
P19838NFKB1Nuclear factor NF-kappa-B p105 subunitT83145SEA
P60568IL2Interleukin-2T61698SEA
Q9UNQ0ABCG2ATP-binding cassette sub-family G member 2T56556SEA
P14679TYRTyrosinaseT97035SEA
O60911CTSVCathepsin (V and K)T93653SEA
P16152CBR1Carbonyl reductase [NADPH] 1T70518SEA
P10599TXNThioredoxinT85616SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T83145DI0218Irritable bowel syndrome[ICD-11: DD91]P19838NFKB1
T83145DI0366Rheumatoid arthritis[ICD-11: FA20]P19838NFKB1
T60366DI0020African trypanosomiasis[ICD-11: 1F51]P11926ODC1
T16347DI0009Acute diabete complication[ICD-11: 5A2Y]P18031PTPN1
T16347DI0062Breast cancer[ICD-11: 2C60-2C6Y]P18031PTPN1
T16347DI0308Obesity[ICD-11: 5B80-5B81]P18031PTPN1
T16347DI0417Type 2 diabetes mellitus[ICD-11: 5A11]P18031PTPN1
T83145DI0218Irritable bowel syndrome[ICD-11: DD91]P19838NFKB1
T83145DI0366Rheumatoid arthritis[ICD-11: FA20]P19838NFKB1
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T56556DI0218Irritable bowel syndrome[ICD-11: DD91]Q9UNQ0ABCG2
T56556DI0366Rheumatoid arthritis[ICD-11: FA20]Q9UNQ0ABCG2
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR
T93653DI0055Bone cancer[ICD-11: 2B5Z]O60911CTSV
T93653DI0087Chronic pain[ICD-11: MG30]O60911CTSV
T70518DI0037Asthma[ICD-11: CA23]P16152CBR1
T85616DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P10599TXN

Copyright © 2025